Marc Lipsitch (M Lipsitch)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 100

Top Venues

Epidemiology (Cambridge, Mass.)

medRxiv : the preprint server for health sciences

The New England journal of medicine

eLife

This page only lists publications with an associated author ORCID identifier.

Publications

Taylor Chin, Ellen F Foxman, Timothy A Watkins, Marc Lipsitch
Considerations for viral co-infection studies in human populations. mBio 15 (7) (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Leon Raphson, Marc Lipsitch
Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023. Epidemiology (Cambridge, Mass.) 35 (3) (2024)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. mBio (2024)
Danielle M Richard, Marc Lipsitch
What's next: using infectious disease mathematical modelling to address health disparities. International journal of epidemiology 53 (1) (2024)
Qifang Bi, Barbra A Dickerman, Huong Q Nguyen, Emily T Martin, Manjusha Gaglani, Karen J Wernli, G K Balasubramani, Brendan Flannery, Marc Lipsitch, Sarah Cobey, null null
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. The Journal of infectious diseases (2024)
Leon Raphson, Marc Lipsitch
Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023. Epidemiology (Cambridge, Mass.) 35 (3) (2024)
Leon Raphson, Marc Lipsitch
Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023. Epidemiology (Cambridge, Mass.) 35 (3) (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Qifang Bi, Barbra A Dickerman, Huong Q Nguyen, Emily T Martin, Manjusha Gaglani, Karen J Wernli, G K Balasubramani, Brendan Flannery, Marc Lipsitch, Sarah Cobey, null null
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. The Journal of infectious diseases (2024)
Leon Raphson, Marc Lipsitch
Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023. Epidemiology (Cambridge, Mass.) 35 (3) (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Leon Raphson, Marc Lipsitch
Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023. Epidemiology (Cambridge, Mass.) 35 (3) (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Taylor Chin, Ellen F Foxman, Timothy A Watkins, Marc Lipsitch
Considerations for viral co-infection studies in human populations. mBio 15 (7) (2024)
Taylor Chin, Ellen F Foxman, Timothy A Watkins, Marc Lipsitch
Considerations for viral co-infection studies in human populations. mBio (2024)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. mBio (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Marc Lipsitch, Thomas V Inglesby, Anita Cicero, David A Relman
Public role in research oversight. Journal of virology 98 (4) (2024)
Taylor Chin, Ellen F Foxman, Timothy A Watkins, Marc Lipsitch
Considerations for viral co-infection studies in human populations. mBio 15 (7) (2024)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. medRxiv : the preprint server for health sciences (2023)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. medRxiv : the preprint server for health sciences (2023)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Katherine Min Jia, Rebecca Kahn, Rebecca Fisher, Sharon Balter, Marc Lipsitch
Geographic Targeting of COVID-19 Testing to Maximize Detection in Los Angeles County. Open forum infectious diseases 10 (7) (2023)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. medRxiv : the preprint server for health sciences (2023)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. medRxiv : the preprint server for health sciences (2023)
Danielle M Richard, Marc Lipsitch
What's next: using infectious disease mathematical modelling to address health disparities. International journal of epidemiology (2023)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. medRxiv : the preprint server for health sciences (2023)
Guilin Li, Hanna Gerlovin, Michael J Figueroa Muñiz, Jessica K Wise, Arin L Madenci, James M Robins, Mihaela Aslan, Kelly Cho, John Michael Gaziano, Marc Lipsitch, Juan Pablo Casas, Miguel A Hernán, Barbra A Dickerman
Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness. Epidemiology (Cambridge, Mass.) 35 (2) (2023)
Eva Rumpler, Justin M Feldman, Mary T Bassett, Marc Lipsitch
Fairness and efficiency considerations in COVID-19 vaccine allocation strategies: A case study comparing front-line workers and 65-74 year olds in the United States. PLOS global public health 3 (2) (2023)
Xueting Qiu, Lesley McGee, Laura L Hammitt, Lindsay R Grant, Katherine L O'Brien, William P Hanage, Marc Lipsitch
Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting. medRxiv : the preprint server for health sciences (2023)
Keya Joshi, Rebecca Kahn, Christopher Boyer, Marc Lipsitch
Some principles for using epidemiologic study results to parameterize transmission models. medRxiv : the preprint server for health sciences (2023)
Kenneth Roy Cohen, Sheng Ren, Kevin Heath, Micah C Dasmariñas, Karol Giuseppe Jubilo, Yinglong Guo, Marc Lipsitch, Sarah E Daugherty
Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical research ed.) 376 (2022)
Lerato E Magosi, Yinfeng Zhang, Tanya Golubchik, Victor DeGruttola, Eric Tchetgen Tchetgen, Vladimir Novitsky, Janet Moore, Pam Bachanas, Tebogo Segolodi, Refeletswe Lebelonyane, Molly Pretorius Holme, Sikhulile Moyo, Joseph Makhema, Shahin Lockman, Christophe Fraser, Myron Max Essex, Marc Lipsitch, null null
Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial - BCPP/Ya Tsie trial. eLife 11 (2022)
Ori Magen, Jacob G Waxman, Maya Makov-Assif, Roni Vered, Dror Dicker, Miguel A Hernán, Marc Lipsitch, Ben Y Reis, Ran D Balicer, Noa Dagan
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. The New England journal of medicine 386 (17) (2022)
Pablo De Salazar, Fred Sun Lu, James A Hay, Gómez-Barroso Diana, Pablo Fernandez-Navarro, Elena V Martínez, Jenaro Astray-Mochales, Rocío Amillategui, Ana García-Fulgueiras, Maria D Chirlaque, Alonso Sánchez-Migallón, Larrauri Amparo, María J Sierra, Marc Lipsitch, Fernando Simón, Mauricio Santillana, Miguel A Hernán
Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data. PLoS computational biology 18 (3) (2022)
Chandra J Cohen-Stavi, Ori Magen, Noam Barda, Shlomit Yaron, Alon Peretz, Doron Netzer, Carlo Giaquinto, Ali Judd, Leonard Leibovici, Miguel A Hernán, Marc Lipsitch, Ben Y Reis, Ran D Balicer, Noa Dagan
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age. The New England journal of medicine 387 (3) (2022)
Edward Goldstein, Bruce H Fireman, Nicola P Klein, Marc Lipsitch, G Thomas Ray
Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018. Epidemiology and infection 150 (2022)
Edward Goldstein, Bruce H Fireman, Nicola P Klein, Marc Lipsitch, G Thomas Ray
Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018. Epidemiology and infection 150 (2022)
Samah Hayek, Galit Shaham, Yatir Ben-Shlomo, Eldad Kepten, Noa Dagan, Daniel Nevo, Marc Lipsitch, Ben Y Reis, Ran D Balicer, Noam Barda
Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Science (New York, N.Y.) 375 (6585) (2022)
Daphne S Sun, Stephen M Kissler, Sanjat Kanjilal, Scott W Olesen, Marc Lipsitch, Yonatan H Grad
Analysis of multiple bacterial species and antibiotic classes reveals large variation in the association between seasonal antibiotic use and resistance. PLoS biology 20 (3) (2022)
Noa Dagan, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A Katz, Miguel A Hernán, Marc Lipsitch, Ben Reis, Ran D Balicer
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. The New England journal of medicine 384 (15) (2021)
Keya Joshi, Eva Rumpler, Lee Kennedy-Shaffer, Rafia Bosan, Marc Lipsitch
Comparative performance of between-population allocation strategies for SARS-CoV-2 vaccines. medRxiv : the preprint server for health sciences (2021)
Sharon K Greene, Sarah F McGough, Gretchen M Culp, Laura E Graf, Marc Lipsitch, Nicolas A Menzies, Rebecca Kahn
Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic. JMIR public health and surveillance 7 (1) (2021)
Kevin C Ma, Tigist F Menkir, Stephen M Kissler, Yonatan Hagai Grad, Marc Lipsitch
Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics. eLife 10 (2021)
Tigist F Menkir, Taylor Chin, James A Hay, Erik D Surface, Pablo De Salazar, Caroline O Buckee, Alexander Watts, Kamran Khan, Ryan Sherbo, Ada W C Yan, Michael J Mina, Marc Lipsitch, Rene Niehus
Estimating internationally imported cases during the early COVID-19 pandemic. Nature communications 12 (1) (2021)
Noam Barda, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A Hernán, Marc Lipsitch, Isaac Kohane, Doron Netzer, Ben Y Reis, Ran D Balicer
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. The New England journal of medicine 385 (12) (2021)
Fred Sun Lu, Andre T Nguyen, Nicholas B Link, Mathieu Molina, Jessica T Davis, Matteo Chinazzi, Xinyue Xiong, Alessandro Vespignani, Marc Lipsitch, Mauricio Santillana
Estimating the cumulative incidence of COVID-19 in the United States using influenza surveillance, virologic testing, and mortality data: Four complementary approaches. PLoS computational biology 17 (6) (2021)
Pablo De Salazar, F Lu, James A Hay, D Gómez-Barroso, P Fernández-Navarro, E Martínez, J Astray-Mochales, R Amillategui, A García-Fulgueiras, M D Chirlaque, A Sánchez-Migallón, A Larrauri, M J Sierra, Marc Lipsitch, F Simón, M Santillana, M A Hernán
Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data. medRxiv : the preprint server for health sciences (2021)
James A Hay, Lee Kennedy-Shaffer, Sanjat Kanjilal, Niall J Lennon, Stacey B Gabriel, Marc Lipsitch, Michael Joseph Mina
Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science (New York, N.Y.) 373 (6552) (2021)
Noa Dagan, Noam Barda, Tal Biron-Shental, Maya Makov-Assif, Calanit Key, Isaac S Kohane, Miguel A Hernán, Marc Lipsitch, Sonia Hernandez-Diaz, Ben Y Reis, Ran D Balicer
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nature medicine 27 (10) (2021)
Ben Y Reis, Noam Barda, Michael Leshchinsky, Eldad Kepten, Miguel A Hernán, Marc Lipsitch, Noa Dagan, Ran D Balicer
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. The New England journal of medicine 385 (22) (2021)
Sarah E Daugherty, Yinglong Guo, Kevin Heath, Micah C Dasmariñas, Karol Giuseppe Jubilo, Jirapat Samranvedhya, Marc Lipsitch, Ken Cohen
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical research ed.) 373 (2021)
Sarah E Cobey, Daniel B Larremore, Yonatan H Grad, Marc Lipsitch
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination. Nature reviews. Immunology 21 (5) (2021)
Marc Lipsitch, Florian Krammer, Gili Regev-Yochay, Yaniv Lustig, Ran D Balicer
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nature reviews. Immunology (2021)
Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum, Ilana Tal, Malka Zavitan, Neta Zuckerman, Adina Bar-Chaim, Yitshak Kreiss, Gili Regev-Yochay
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. The New England journal of medicine 385 (16) (2021)
Kate M Bubar, Kyle Reinholt, Stephen M Kissler, Marc Lipsitch, Sarah E Cobey, Yonatan Hagai Grad, Daniel B Larremore
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science (New York, N.Y.) 371 (6532) (2021)
Pablo De Salazar, D Gómez-Barroso, D Pampaka, J M Gil, B Peñalver, C Fernández-Escobar, Marc Lipsitch, A Larrauri, E Goldstein, M A Hernán
Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain. Epidemiology and infection 148 (2020)
Marc Lipsitch, David L Swerdlow, Lyn Finelli
Defining the Epidemiology of Covid-19 - Studies Needed. The New England journal of medicine 382 (13) (2020)
Sonja Lehtinen, Claire Chewapreecha, John A Lees, William P Hanage, Marc Lipsitch, Nicholas J Croucher, Stephen D Bentley, Paul Turner, Christophe Fraser, Rafal J Mostowy
Horizontal gene transfer rate is not the primary determinant of observed antibiotic resistance frequencies in Streptococcus pneumoniae. Science advances 6 (21) (2020)
Derek R MacFadden, Bryan Coburn, Karel Břinda, Antoine Corbeil, Nick Daneman, David Fisman, Robyn S Lee, Marc Lipsitch, Allison McGeer, Roberto Gustavo Melano, Samira Mubareka, William P Hanage
Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli. Antimicrobial agents and chemotherapy 64 (5) (2020)
Sarah F McGough, Michael A Johansson, Marc Lipsitch, Nicolas A Menzies
Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking. PLoS computational biology 16 (4) (2020)
Allison L Hicks, Stephen M Kissler, Tatum D Mortimer, Kevin C Ma, George Taiaroa, Melinda Ashcroft, Deborah Ann Williamson, Marc Lipsitch, Yonatan Hagai Grad
Targeted surveillance strategies for efficient detection of novel antibiotic resistance variants. eLife 9 (2020)
Lee Kennedy-Shaffer, Marc Lipsitch
Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease Outbreaks. medRxiv : the preprint server for health sciences (2020)
Thomas V Inglesby, Marc Lipsitch
Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation. mSphere 5 (1) (2020)
Thuy Doan, Lee Worden, Armin Hinterwirth, Ahmed M Arzika, Ramatou Maliki, Amza Abdou, Lina Zhong, Cindi Chen, Catherine Cook, Elodie Lebas, Kieran S O'Brien, Catherine E Oldenburg, Eric D Chow, Travis C Porco, Marc Lipsitch, Jeremy D Keenan, Thomas M Lietman
Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. The New England journal of medicine 383 (20) (2020)
Marc Lipsitch, Yonatan H Grad, Alessandro Sette, Shane Crotty
Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nature reviews. Immunology 20 (11) (2020)
Edward Goldstein, Marc Lipsitch
Temporal rise in the proportion of both younger adults and older adolescents among COVID-19 cases in Germany: evidence of lesser adherence to social distancing practices? medRxiv : the preprint server for health sciences (2020)
Taj Azarian, Pamela P Martinez, Brian J Arnold, Xueting Qiu, Lindsay R Grant, Jukka Corander, Christophe Fraser, Nicholas J Croucher, Laura L Hammitt, Raymond Reid, Mathuram Santosham, Robert C Weatherholtz, Stephen D Bentley, Katherine L O'Brien, Marc Lipsitch, William P Hanage
Frequency-dependent selection can forecast evolution in Streptococcus pneumoniae. PLoS biology 18 (10) (2020)
Stephen M Kissler, Christine Tedijanto, Edward Goldstein, Yonatan Hagai Grad, Marc Lipsitch
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science (New York, N.Y.) 368 (6493) (2020)
Marc Lipsitch, Rebecca Kahn, Michael J Mina
Antibody testing will enhance the power and accuracy of COVID-19-prevention trials. Nature medicine 26 (6) (2020)
Meira Levinson, Muge Cevik, Marc Lipsitch
Reopening Primary Schools during the Pandemic. The New England journal of medicine 383 (10) (2020)
Christine Tedijanto, Yonatan Hagai Grad, Marc Lipsitch
Potential impact of outpatient stewardship interventions on antibiotic exposures of common bacterial pathogens. eLife 9 (2020)
Katelyn M Gostic, Lauren McGough, Edward B Baskerville, Sam Abbott, Keya Joshi, Christine Tedijanto, Rebecca Kahn, Rene Niehus, James A Hay, Pablo De Salazar, Joel Hellewell, Sophie Meakin, James D Munday, Nikos I Bosse, Katharine Sherrat, Robin N Thompson, Laura F White, Jana Sanne Huisman, Jérémie Scire, Sebastian Bonhoeffer, Tanja Stadler, Jacco Wallinga, Sebastian Funk, Marc Lipsitch, Sarah E Cobey
Practical considerations for measuring the effective reproductive number, Rt. PLoS computational biology 16 (12) (2020)
Scott W Olesen, Marc Lipsitch, Yonatan Hagai Grad
Response to comment on 'The distribution of antibiotic use and its association with antibiotic resistance'. eLife 8 (2019)
Lee Kennedy-Shaffer, Victor de Gruttola, Marc Lipsitch
Novel methods for the analysis of stepped wedge cluster randomized trials. Statistics in medicine 39 (7) (2019)
Sonja Lehtinen, François Blanquart, Marc Lipsitch, Christophe Fraser, null null
On the evolutionary ecology of multidrug resistance in bacteria. PLoS pathogens 15 (5) (2019)
Allison L Hicks, Stephen M Kissler, Marc Lipsitch, Yonatan Hagai Grad
Surveillance to maintain the sensitivity of genotype-based antibiotic resistance diagnostics. PLoS biology 17 (11) (2019)
Kate E Langwig, M Gabriela M Gomes, Mercedes D Clark, Molly Kwitny, Steffany Yamada, Andrew R Wargo, Marc Lipsitch
Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure dose. Scientific reports 9 (1) (2019)
Nadia N Abuelezam, Yakir A Reshef, David Novak, Yonatan Hagai Grad, George R Seage Iii, Kenneth H Mayer, Marc Lipsitch
Interaction Patterns of Men Who Have Sex With Men on a Geosocial Networking Mobile App in Seven United States Metropolitan Areas: Observational Study. Journal of medical Internet research 21 (9) (2019)
Sukhyun Ryu, Benjamin J Cowling, Peng Wu, Scott W Olesen, Christophe Fraser, Daphne S Sun, Marc Lipsitch, Yonatan H Grad
Case-based surveillance of antimicrobial resistance with full susceptibility profiles. JAC-antimicrobial resistance 1 (3) (2019)
Marc Lipsitch, E Goldstein, G T Ray, B Fireman
Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results. Epidemiology and infection 147 (2019)
Marc Lipsitch, Nir Eyal
Improving vaccine trials in infectious disease emergencies. Science (New York, N.Y.) 357 (6347) (2018)
Scott W Olesen, Michael L Barnett, Derek R MacFadden, John S Brownstein, Sonia Hernández-Díaz, Marc Lipsitch, Yonatan Hagai Grad
The distribution of antibiotic use and its association with antibiotic resistance. eLife 7 (2018)
Rebecca Kahn, Annette Rid, Peter G Smith, Nir Eyal, Marc Lipsitch
Choices in vaccine trial design in epidemics of emerging infections. PLoS medicine 15 (8) (2018)
Taj Azarian, Lindsay R Grant, Brian J Arnold, Laura L Hammitt, Raymond Reid, Mathuram Santosham, Robert Weatherholtz, Novalene Goklish, Claudette M Thompson, Stephen D Bentley, Katherine L O'Brien, William P Hanage, Marc Lipsitch
The impact of serotype-specific vaccination on phylodynamic parameters of Streptococcus pneumoniae and the pneumococcal pan-genome. PLoS pathogens 14 (4) (2018)
Joseph J Campo, Timothy Q Le, Jozelyn V Pablo, Christopher Hung, Andy A Teng, Hervé Tettelin, Andrea Tate, William P Hanage, Mark R Alderson, Xiaowu Liang, Richard Malley, Marc Lipsitch, Nicholas J Croucher
Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination. eLife 7 (2018)
Maria Georgieva, L Kagedan, Ying-Jie Lu, C M Thompson, Marc Lipsitch
Antigenic Variation in Streptococcus pneumoniae PspC Promotes Immune Escape in the Presence of Variant-Specific Immunity. mBio 9 (2) (2018)
Francisco Y Cai, Thomas Fussell, Sarah Cobey, Marc Lipsitch
Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine. PLoS computational biology 14 (10) (2018)
Michael A Johansson, Nicholas G Reich, Lauren Ancel Meyers, Marc Lipsitch
Preprints: An underutilized mechanism to accelerate outbreak science. PLoS medicine 15 (4) (2018)
Matt David Thomas Hitchings, Rebecca Freeman Grais, Marc Lipsitch
Using simulation to aid trial design: Ring-vaccination trials. PLoS neglected tropical diseases 11 (3) (2017)
Kate E Langwig, Andrew R Wargo, Darbi R Jones, Jessie R Viss, Barbara J Rutan, Nicholas A Egan, Pedro Sá-Guimarães, Min Sun Kim, Gael Kurath, M Gabriela M Gomes, Marc Lipsitch
Vaccine Effects on Heterogeneity in Susceptibility and Implications for Population Health Management. mBio 8 (6) (2017)
Marc Lipsitch, Wendy Barclay, Rahul Raman, Charles J Russell, Jessica A Belser, Sarah Cobey, Peter M Kasson, James O Lloyd-Smith, Sebastian Maurer-Stroh, Steven Riley, Catherine A A Beauchemin, Trevor Bedford, Thomas C Friedrich, Andreas Handel, Sander Herfst, Pablo Ramiro Murcia, Benjamin Roche, Claus O Wilke, Colin A Russell
Viral factors in influenza pandemic risk assessment. eLife 5 (2016)

Marc Lipsitch.css-eqlu8i{font-size:small;padding-left:4px;} (M Lipsitch)

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Lipsitch (M Lipsitch)